PURE Bioscience, Inc. (PURE) Net margin 2017–2025
PURE Bioscience, Inc. (PURE) net profit margin by fiscal year — reported net income divided by reported revenue.
-108.9%FY2025 · since FY2017: -342.1% → -108.9%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -108.9% | +61.7 pp |
| FY2024 | -170.7% | +40.4 pp |
| FY2023 | -211.0% | -22.6 pp |
| FY2022 | -188.4% | -129.3 pp |
| FY2021 | -59.1% | -59.1 pp |
| FY2020 | 0.1% | +343.4 pp |
| FY2019 | -343.3% | +76.2 pp |
| FY2018 | -419.5% | -77.5 pp |
| FY2017 | -342.1% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice